BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28482727)

  • 1. Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience.
    Byun JM; Kim KH; Kim M; Kim TM; Jeon YK; Park JH; Paik JH; Lee JM; Lee HY; Lee JS; Heo DS; Lee JO
    Leuk Lymphoma; 2017 Nov; 58(11):2624-2632. PubMed ID: 28482727
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Tan X; Sun X; Yuan H; He L; Ding C; Jiang L
    Hell J Nucl Med; 2022; 25(3):285-296. PubMed ID: 36507885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response.
    Gykiere P; Jans L; Degrieck B; Goethals I
    Clin Nucl Med; 2016 Feb; 41(2):142-3. PubMed ID: 26402124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
    Jeong J; Kim SW; Sung DH
    J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
    Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
    J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary Neurolymphomatosis of the Radial Nerve: A Diagnostic Challenge.
    Iacobellis F; Di Serafino M; Blasio R; Barbuto L; Pezzullo F; Romano L
    Am J Case Rep; 2019 Nov; 20():1652-1658. PubMed ID: 31707401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
    Lin M; Kilanowska J; Taper J; Chu J
    Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell peripheral neurolymphomatosis: MRI and
    DeVries AH; Howe BM; Spinner RJ; Broski SM
    Skeletal Radiol; 2019 Jul; 48(7):1043-1050. PubMed ID: 30666391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case.
    Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X
    Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature.
    Del Grande A; Sabatelli M; Luigetti M; Conte A; Granata G; Rufini V; Del Ciello A; Gaudino S; Fernandez E; Hohaus S; Coli A; Lauriola L
    Muscle Nerve; 2014 Dec; 50(6):1016-22. PubMed ID: 25088432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurolymphomatosis of the peripheral nervous system: a case report and review of the literature.
    Sideras PA; Matthews J; Sakib SM; Ofikwu F; Spektor V
    Clin Imaging; 2016; 40(6):1253-1256. PubMed ID: 27636384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach.
    Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS
    J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of
    Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
    Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes.
    Davidson T; Kedmi M; Avigdor A; Komisar O; Chikman B; Lidar M; Goshen E; Tzila Zwas S; Ben-Haim S
    Leuk Lymphoma; 2018 Feb; 59(2):348-356. PubMed ID: 28750592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D; Patti C; Lagalla R; Midiri M; Galia M
    J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
    Akkas BE; Vural GU
    Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurolymphomatosis: MRI and (18) FDG-PET features.
    Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
    Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
    Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
    Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes.
    Kamiya-Matsuoka C; Shroff S; Gildersleeve K; Hormozdi B; Manning JT; Woodman KH
    J Neurol Sci; 2014 Aug; 343(1-2):144-8. PubMed ID: 24928074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.